Model for End-Stage Liver Disease Exceptions in the Context of the French Model for End-Stage Liver Disease Score-Based Liver Allocation System

被引:67
作者
Francoz, Claire [1 ,8 ]
Belghiti, Jacques [2 ]
Castaing, Denis [3 ]
Chazouilleres, Olivier [4 ]
Duclos-Vallee, Jean-Charles [3 ]
Duvoux, Christophe [5 ]
Lerut, Jan [6 ]
Le Treut, Yves-Patrice [7 ]
Moreau, Richard [8 ]
Mandot, Ameet [1 ]
Pageaux, Georges [9 ]
Samuel, Didier [3 ]
Thabut, Dominique [10 ]
Valla, Dominique [1 ,8 ]
Durand, Francois [1 ,8 ]
机构
[1] Beaujon Hosp, Dept Hepatol, F-92110 Clichy, France
[2] Beaujon Hosp, Dept Hepatobiliary & Pancreat Surg, F-92110 Clichy, France
[3] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France
[4] St Antoine Hosp, Dept Hepatol, Paris, France
[5] Henri Mondor Hosp, Dept Hepatol, Creteil, France
[6] St Luc Univ Hosp, Dept Abdominal & Transplantat Surg, Brussels, Belgium
[7] Hosp Concept, Dept Digest Surg, Marseille, France
[8] Natl Inst Hlth & Med Res, U773, Bichat Beaujon Ctr Biomed Res CRB3, Paris, France
[9] St Eloi Hosp, Dept Hepatol, Montpellier, France
[10] Hop La Pitie Salpetriere, Dept Hepatol, Paris, France
关键词
HEREDITARY HEMORRHAGIC TELANGIECTASIA; INTRAHEPATIC PORTOSYSTEMIC SHUNT; HUMAN-IMMUNODEFICIENCY-VIRUS; QUALITY-OF-LIFE; POLYTETRAFLUOROETHYLENE-COVERED STENT; NODULAR REGENERATIVE HYPERPLASIA; BUDD-CHIARI-SYNDROME; HEPATITIS-B-VIRUS; POLYCYSTIC LIVER; PORTOPULMONARY HYPERTENSION;
D O I
10.1002/lt.22363
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not significantly affect posttransplant survival. The MELD score can be used to optimize the allocation of allografts according to a sickest first policy. Most often, patients with small hepatocellular carcinomas (HCCs) and low MELD scores receive extra points, which allow them appropriate access to transplantation comparable to the access of patients with advanced cirrhosis and high MELD scores. In addition to patients with advanced cirrhosis and HCC, patients with a number of relatively uncommon conditions have low MELD scores and a poor prognosis in the short term without transplantation but derive excellent benefits from transplantation. These conditions, which correspond to the so-called MELD score exceptions, justify the allocation of a specific score for appropriate access to transplantation. Here we report the conclusions of the French consensus meeting. The goals of this meeting were (1) to identify which conditions merit MELD score exceptions, (2) to list the criteria needed for defining each of these conditions, and (3) to define a reasonable time interval for organ allocation for each MELD exception in the general context of organ shortages. MELD exceptions were discussed in an attempt to reconcile the concepts of transparency, equity, justice, and utility. Liver Transpl 17: 1137-1151, 2011. (C) 2011 AASLD.
引用
收藏
页码:1137 / 1151
页数:15
相关论文
共 123 条
[81]   Outcomes of liver transplantation in HIV-infected individuals: The impact of HCV and HBV infection [J].
Norris, S ;
Taylor, C ;
Muiesan, P ;
Portmann, BC ;
Knisely, AS ;
Bowles, M ;
Rela, M ;
Heaton, N ;
O'Grady, JG .
LIVER TRANSPLANTATION, 2004, 10 (10) :1271-1278
[82]   EARLY INDICATORS OF PROGNOSIS IN FULMINANT HEPATIC-FAILURE [J].
OGRADY, JG ;
ALEXANDER, GJM ;
HAYLLAR, KM ;
WILLIAMS, R .
GASTROENTEROLOGY, 1989, 97 (02) :439-445
[83]   Treatment of resistant pruritus from cholestasis with albumin dialysis: Combined analysis of patients from three centers [J].
Pares, Albert ;
Herrera, Manuel ;
Aviles, Juan ;
Sanz, Miguel ;
Mas, Antoni .
JOURNAL OF HEPATOLOGY, 2010, 53 (02) :307-312
[84]   Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States [J].
Patel, T .
HEPATOLOGY, 2001, 33 (06) :1353-1357
[85]   Surgical treatment in proximal bile duct cancer - A single-center experience [J].
Pichlmayr, R ;
Weimann, A ;
Klempnauer, J ;
Oldhafer, KJ ;
Maschek, H ;
Tusch, G ;
Ringe, B .
ANNALS OF SURGERY, 1996, 224 (05) :628-638
[86]   Liver transplantation for polycystic liver disease [J].
Pirenne, J ;
Aerts, R ;
Yoong, K ;
Gunson, B ;
Koshiba, T ;
Fourneau, I ;
Mayer, D ;
Buckels, J ;
Mirza, D ;
Roskams, T ;
Elias, E ;
Nevens, F ;
Fevery, J ;
McMaster, P .
LIVER TRANSPLANTATION, 2001, 7 (03) :238-245
[87]   Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome [J].
Plessier, Aurelie ;
Sibert, Annie ;
Consigny, Yann ;
Hakime, Antoine ;
Zappa, Magaly ;
Denninger, Marie-Helene ;
Condat, Bertrand ;
Farges, Olivier ;
Chagneau, Carine ;
de Ledinghen, Victor ;
Francoz, Claire ;
Sauvanet, Alain ;
Vilgrain, Valerie ;
Belghiti, Jacques ;
Durand, Francois ;
Valla, Dominique .
HEPATOLOGY, 2006, 44 (05) :1308-1316
[88]   Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy [J].
Pomfret, EA ;
Lewis, WD ;
Jenkins, RL ;
Bergethon, P ;
Dubrey, SW ;
Reisinger, J ;
Falk, RH ;
Skinner, M .
TRANSPLANTATION, 1998, 65 (07) :918-925
[89]   Report of a National conference on Liver Allocation in Patients with Hepatocellular Carcinoma in the United States [J].
Pomfret, Elizabeth A. ;
Washburn, Kenneth ;
Wald, Christoph ;
Nalesnik, Michael A. ;
Douglas, David ;
Russo, Mark ;
Roberts, John ;
Reich, David J. ;
Schwartz, Myron E. ;
Mieles, Luis ;
Lee, Fred T. ;
Florman, Sander ;
Yao, Francis ;
Harper, Ann ;
Edwards, Erick ;
Freeman, Richard ;
Lake, John .
LIVER TRANSPLANTATION, 2010, 16 (03) :262-278
[90]   Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease [J].
Ragni, MV ;
Eghtesad, B ;
Schlesinger, KW ;
Dvorchik, I ;
Fung, JJ .
LIVER TRANSPLANTATION, 2005, 11 (11) :1425-1430